| Bliss GVS Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506197 |
NSE Symbol : BLISSGVS |
P/E(TTM) : 23.08 |
|
ISIN Demat : INE416D01022 |
Div & Yield% : 0.29 |
EPS(TTM) : 7.41 |
|
Book Value(₹) : 104.39 |
Market Cap(₹Cr) : 1,808.38 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 190.23 | 163.36 | 156.00 | 179.59 | 182.65 | 148.96 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 190.23 | 163.36 | 156.00 | 179.59 | 182.65 | 148.96 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 25.84 | 10.59 | 9.36 | 11.66 | 8.35 | 6.84 |
| Total Income | 216.07 | 173.96 | 165.36 | 191.25 | 191.00 | 155.80 |
| Total Expenditure | 172.21 | 130.60 | 142.27 | 153.86 | 157.27 | 122.22 |
| PBIDT | 43.86 | 43.36 | 23.09 | 37.40 | 33.73 | 33.58 |
| Interest | 2.71 | 5.11 | 1.30 | 0.67 | 3.45 | 1.17 |
| PBDT | 41.15 | 38.25 | 21.79 | 36.73 | 30.29 | 32.41 |
| Depreciation | 7.69 | 7.68 | 7.43 | 6.96 | 6.39 | 6.26 |
| Tax | 11.41 | 12.55 | 3.95 | 10.27 | 8.74 | 7.03 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.75 | -3.04 | -1.04 | -1.55 | -1.90 | -0.29 |
| Reported Profit After Tax | 24.79 | 21.05 | 11.45 | 21.05 | 17.04 | 19.42 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 24.79 | 21.05 | 11.45 | 21.05 | 17.04 | 19.42 |
| EPS (Unit Curr.) | 2.35 | 2.00 | 1.08 | 2.00 | 1.63 | 1.85 |
| EPS (Adj) (Unit Curr.) | 2.35 | 2.00 | 1.08 | 2.00 | 1.63 | 1.85 |
| Calculated EPS (Unit Curr.) | 2.35 | 2.00 | 1.09 | 2.00 | 1.62 | 1.85 |
| Calculated EPS (Adj) (Unit Curr.) | 2.35 | 2.00 | 1.09 | 2.00 | 1.62 | 1.85 |
| Calculated EPS (Ann.) (Unit Curr.) | 9.39 | 7.98 | 4.35 | 7.99 | 6.48 | 7.41 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 9.39 | 7.98 | 4.35 | 7.99 | 6.48 | 7.41 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.56 | 10.55 | 10.54 | 10.54 | 10.51 | 10.49 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.06 | 26.54 | 14.80 | 20.83 | 18.47 | 22.54 |
| PBDTM(%) | 21.63 | 23.41 | 13.97 | 20.45 | 16.58 | 21.76 |
| PATM(%) | 13.03 | 12.89 | 7.34 | 11.72 | 9.33 | 13.04 |